Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Other Non Operating Income: 2011-2025

Historic Other Non Operating Income for Ani Pharmaceuticals (ANIP) over the last 15 years, with Sep 2025 value amounting to -$853,000.

  • Ani Pharmaceuticals' Other Non Operating Income rose 88.58% to -$853,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year increase of 16.23%. This contributed to the annual value of -$7.5 million for FY2024, which is 4596.86% down from last year.
  • As of Q3 2025, Ani Pharmaceuticals' Other Non Operating Income stood at -$853,000, which was down 149.05% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Other Non Operating Income registered a high of $1.7 million during Q2 2025, and its lowest value of -$7.5 million during Q3 2024.
  • Over the past 3 years, Ani Pharmaceuticals' median Other Non Operating Income value was -$36,500 (recorded in 2023), while the average stood at -$666,300.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 19,048.72% in 2024, then skyrocketed by 2,076.14% in 2025.
  • Ani Pharmaceuticals' Other Non Operating Income (Quarterly) stood at -$2.7 million in 2021, then surged by 98.44% to -$42,000 in 2022, then increased by 21.43% to -$33,000 in 2023, then tumbled by 19,048.72% to -$7.5 million in 2024, then soared by 88.58% to -$853,000 in 2025.
  • Its Other Non Operating Income was -$853,000 in Q3 2025, compared to $1.7 million in Q2 2025 and $198,000 in Q1 2025.